CIK 0001641489 · Non-accelerated filer<br>Smaller reporting company
vTv Therapeutics Inc.
Sign in to watch- Ticker
- VTVT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473916571
- Phone
- 336-841-0300
- Business address
- 3980 PREMIER DR, SUITE 310, HIGH POINT, NC, 27265
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-10 | AKKARAJU SRINIVAS Director | Grant or award · Director stock option (right to buy) | +4,000 | $16.59 | $66K | 10,983 |
| 2025-06-10 | Phillips Anne M. Director | Grant or award · Director stock option (right to buy) | +4,000 | $16.59 | $66K | 10,860 |
| 2025-06-10 | Al-Marzooqi Fahed Director | Grant or award · Director stock option (right to buy) | +4,000 | $16.59 | $66K | 13,555 |
| 2025-06-10 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +4,000 | 4,000 | ||
| 2025-06-10 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +4,000 | 4,000 | ||
| 2025-05-19 | Tung Michael Stephen EVP & CFO | Grant or award · Employee stock option (right to buy) | +45,000 | $21.25 | $956K | 45,000 |
| 2025-03-01 | SEKHRI PAUL J Pres, CEO and Exec Chairperson | Grant or award · Employee stock option (right to buy) | +108,000 | $19.66 | $2.1M | 252,212 |
| 2024-11-18 | SEKHRI PAUL J Pres, CEO and Exec Chairperson | Purchase 10b5-1 | +1,844 | $16.96 | $31K | 5,000 |
| 2024-11-15 | SEKHRI PAUL J Pres, CEO and Exec Chairperson | Purchase 10b5-1 | +1,378 | $16.35 | $23K | 1,378 |
| 2024-11-15 | SEKHRI PAUL J Pres, CEO and Exec Chairperson | Purchase 10b5-1 | +1,778 | $16.88 | $30K | 3,156 |
| 2024-06-25 | AKKARAJU SRINIVAS Director | Grant or award · Director stock option (right to buy) | +2,250 | $17.22 | $39K | 6,000 |
| 2024-06-25 | AKKARAJU SRINIVAS Director | Grant or award · Director stock option (right to buy) | +983 | $17.22 | $17K | 6,983 |
| 2024-06-25 | SPIEGELMAN DANIEL K Director | Grant or award · Director stock option (right to buy) | +6,000 | $17.22 | $103K | 6,000 |
| 2024-06-25 | Al-Marzooqi Fahed Director | Grant or award · Director stock option (right to buy) | +3,000 | $17.22 | $52K | 9,555 |
| 2024-06-25 | Phillips Anne M. Director | Grant or award · Director stock option (right to buy) | +2,250 | $17.22 | $39K | 6,000 |
| 2024-06-25 | Phillips Anne M. Director | Grant or award · Director stock option (right to buy) | +860 | $17.22 | $15K | 6,860 |
| 2024-06-25 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2024-06-25 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2024-06-25 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +983 | 983 | ||
| 2024-06-25 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +983 | 983 |
Page 2 of 13 · 256 trades